Physician Lead of Research, Medical Director of Immunohistochemistry and Molecular Pathology, Department of Pathology, William Osler Health System
BIOGRAPHY
APR 29, 2021 12:05 PM PDT
Point of care NGS in community practice
Presented at:
OncomineWorld 2022: A Virtual NGS Education Meeting
Speaker
Abstract
This session will outline the challenges faced by community-based oncologists and pathologists in practicing precision medicine. Focusing on biomarker delivery in lung cancer, the talk will outline difficulties, essential components, and keys for success, in delivering these results so as to maximize their clinical utility. Finally, we will explore some additional benefits that rapidly-delivered NGS can bring to a clinical practice.
Learning Objectives:
1. Be able to outline key lung cancer biomarkers associated with patient care
2. Have in-depth understanding of the obstacles of single-gene testing for diagnosis
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...